Physician Assistant Program year 2025 Reported 2024–2025 Source: CMS Open Payments, 2026 publication

Molly Coogan

Physician Assistant, Medical Pawtucket, RI Physician Assistant

NPI 1366232456 CMS profile 11855447

333 School St Ste 112A, Pawtucket, RI 02860

Open in the dashboard

General payments

$1,182

46 records reported · program years 2024–2025

Research payments

$0

Paid to them · None reported · program years 2024–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Molly Coogan of Pawtucket, RI is reported in the CMS Open Payments database as having received $1,182 across 46 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 67th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,160 45
2024 General $23 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Molly Coogan
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Molly Coogan were reported at $1,160. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Molly Coogan Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $0 $156 $41–$563 $132
2022 $0 $185 $55–$649 $149
2023 $0 $199 $58–$717 $160
2024 $23 $206 $62–$740 $164
2025 $1,160 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2024–2025
  1. AbbVie, Inc. $182 13 payments
  2. Regeneron Healthcare Solutions, Inc. $177 4 payments
  3. Arcutis Biotherapeutics, Inc. $163 3 payments
  4. LEO Pharma Inc. $142 4 payments
  5. Incyte Corporation $116 4 payments
  6. Janssen Biotech, Inc. $81 3 payments
  7. Amgen Inc. $73 3 payments
  8. UCB, Inc. $66 3 payments
  9. Genzyme Corporation $54 2 payments
  10. Sun Pharmaceutical Industries Inc. $51 3 payments
  11. Other $78 4 payments

Every payment, record by record

What the payments were for General payments · program years 2024–2025
  1. Food and Beverage $1,088 45 payments
  2. Education $95 1 payment
Products named General payments · program years 2024–2025
  1. DUPIXENT Immunology And Inflammation $177 4 payments
  2. Zoryve $163 3 payments
  3. OPZELURA $116 4 payments
  4. SKYRIZI $115 7 payments
  5. ADBRY $85 3 payments
  6. TREMFYA $81 3 payments
  7. Otezla $73 3 payments
  8. Bimzelx $66 3 payments
  9. ANZUPGO $58 1 payment
  10. DUPIXENT Immunology $54 2 payments
  11. Other $237 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

46 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Rhode Island

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record